C38H72N2O12
749 g/mol
原薬危険
Azithromycin
アジスロマイシン
CAS83905-01-5
用途カテゴリー
原薬
化合物分類
天然物
主な用途
医薬原料
Azithromycin is a macrolide antibiotic active pharmaceutical ingredient used in the manufacture of medications for bacterial infections. It is commonly supplied as a raw material for pharmaceutical formulations targeting respiratory, gastrointestinal, and sexually transmitted infections.
Pharmaceutical raw material for antibiotic medicationsCompound used in manufacturing treatments for bacterial infectionsActive ingredient in formulations for respiratory and gastrointestinal infections
コンテンツの範囲: 本ページの情報は、化学品の識別および産業供給・研究開発・製造の文脈を対象としています。治療効果の主張、医療助言、または医薬品の使用指示には該当しません。
この化合物を調達・供給しますか？
在庫を登録するか、購入リクエストを投稿してください
CAS 83905-01-5
関連化合物
強い関連同一母体構造
AZITHROMYCIN DIHYDRATE
CAS117772-70-0
医薬原料
強い関連同一母体構造
Azithromycin Monohydrate
CAS121470-24-4
医薬原料
強い関連構造類似類似度 0.88
Azithromycin C
CAS620169-47-3
医薬原料
類似構造類似類似度 0.83
Azithromycin B
CAS307974-61-4
医薬原料
参考同カテゴリ
Lisinopril dihydrate
CAS83915-83-7
医薬原料
参考同カテゴリ
フランカルボン酸モメタゾン
CAS83919-23-7
医薬原料
参考同カテゴリ
Somatorelin
CAS83930-13-6
医薬原料
参考同カテゴリ
カリプラジン
CAS839712-12-8
医薬原料
安全参照
危険
H317May cause an allergic skin reaction
H334May cause allergy or asthma symptoms or breathing difficulties if inhaled
H372Causes damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
識別子
IUPAC名
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
InChIKey
MQTOSJVFKKJCRP-BICOPXKESA-N
SMILES
CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
別名一覧 (102)
- A-9941
- ZIT
- Azithromycin (INN)
- Azithromycin Identity, United States Pharmacopeia (USP)
- Azithromycin [EP monograph]
- Azithromycin for peak identification, European Pharmacopoeia (EP)
- Azithromycin for system suitability, European Pharmacopoeia (EP)
- Azithromycin, European Pharmacopoeia (EP)
- Anhydrous azithromycin
- Aritromicina
- Aritromicina [Spanish]
- Aruzilina
- Azadose
- Azasite
- Azasite (TN)
- Azenil
- Azifast
- Azigram
- Azimakrol
- Azithramycine
- Azithrocin
- Azithromycin (Zithromax)
- Azithromycin (as dihydrate)
- Azithromycin CRS
- Azithromycin hydrate
- Azithromycine
- Azithromycine [French]
- Azithromycinum
- Azithromycinum [Latin]
- Azitrocin
- Azitromicina
- Azitromicina [Spanish]
- Azitromicine
- Azitromin
- Aziwin
- Aziwok
- Aztrin
- Azyter
- Azythromycin
- CP-62,993
- Clamelle
- Dihydrate, Azithromycin
- DuraSite
- Hemomycin
- Macrozit
- Mixoterin
- Monohydrate, Azithromycin
- Ribotrex;
- Setron
- Spiramycin CRS
- Sumamed
- Sunamed
- Tobil
- Toraseptol
- Trezid;
- Trozocina
- Trulimax
- Ultreon
- Xithrone
- Z-Pak
- Z-Pak (Azithromycin)
- Zentavion
- Zeto
- Zifin
- Zithrax
- Zithromac
- Zithromax
- Zithromax IV
- Zithromycin
- Zitrim
- Zitromax
- Zitromax Avium 600
- Zitrotek
- Zmas
- Zmax
- Zmax SR
- Zythromax
- aziromycin
- azithromycin
- azithromycin anhydrous